Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Nivalis Therapeutics NVLS

Healthcare Biotechnology
"Nivalis Therapeutics Inc is engaged in developing small molecule therapeutics for the treatment of diseases such as cystic fibrosis, asthma, chronic obstructive pulmonary disease, inflammatory bowel disease and certain cardiovascular disorders."

Recent & Breaking News (NDAQ:NVLS)

Alpine Immune Sciences, Inc. Completes Merger with Nivalis Therapeutics, Inc.

Business Wire July 25, 2017

Nivalis Therapeutics Announces Results of Special Meeting of Stockholders

Business Wire July 20, 2017

Nivalis Therapeutics, Inc. Sets Date for Special Meeting of Stockholders

Business Wire June 2, 2017

How These Biotech Stocks are Faring? -- ContraVir Pharma, Intra-Cellular Therapies, Nivalis Therapeutics, and OncoSec Medical

PR Newswire May 2, 2017

Nivalis Therapeutics Reports First Quarter 2017 Financial Results

Business Wire May 1, 2017

15 Biggest Mid-Day Losers For Wednesday

Benzinga.com  April 19, 2017

22 Stocks Moving In Wednesday's Pre-Market Session

Benzinga.com  April 19, 2017

Wall Street's M&A Chatter From April 18: Akorn, Cardinal Health, Post-Weetabix, Nivalis Therapeutics-Alpine Immune

Benzinga.com  April 19, 2017

15 Biggest Mid-Day Gainers For Tuesday

Benzinga.com  March 14, 2017

How These Biotech Stocks are Faring? -- Corbus Pharma, Advaxis, Vanda Pharma, and Nivalis Therapeutics

PR Newswire March 7, 2017

Nivalis Therapeutics Announces Results from Phase 2 Clinical Trial of Cavosonstat Added to Ivacaftor for Treatment of Cystic Fibrosis

GlobeNewswire February 23, 2017

Nivalis Therapeutics Reports Fourth Quarter and Full-Year 2016 Financial Results

GlobeNewswire February 13, 2017

12 Biggest Mid-Day Gainers For Friday

Benzinga.com  January 13, 2017

Nivalis Therapeutics Announces Corporate Restructuring

GlobeNewswire January 12, 2017

18 Biggest Mid-Day Gainers For Wednesday

Benzinga.com  January 4, 2017

Nivalis Therapeutics Announces Review of Strategic Alternatives

GlobeNewswire January 3, 2017

10 Biggest Mid-Day Gainers For Friday

Benzinga.com  December 30, 2016

18 Stocks Moving In Friday's Pre-Market Session

Benzinga.com  December 30, 2016

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Nivalis Therapeutics, Inc. (NVLS)

PR Newswire November 29, 2016

Looking For Leftover Value in Nivalis Following Drug Trial Miss

Benzinga.com  November 29, 2016